找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

新窗
投票 ESCI期刊Pharmaceutical Care Espana 2024/2025影响因子:0.567 (PHARM CARE ESP) (1139-6202). (PHARMACOLOGY & PHARMACY)(药理学与药学)Eme  ...234
Total Citations:62; 2023 JIF:0.567; JIFRank: 331/354 ; Rank-JIF: 331; Number-of-JIF:354; 5 Year JIF:0.306; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.4; Immediacy Index:<0.1; Immediacy Index-dealt:0.046; 2023 JCI:0.03; JCI Rank: 350/354 ; Total Articles:17; JCI Quartile:Q4; JCI Percentile:1.27; Eigenfactor:0; Normalized Eigenfactor:0.006; Article Influence Score:0.033; JIF Percentile:6.6; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:19; % of Articles in Citable items:0.8947; Cited Half-Life:NULL; Citing Half-Life:7.7; % of OA Gold:0.1379; Publisher name:AME PUBLISHING COMPANY; Publisher address:FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3
投票 ESCI期刊Recent Advances in Inflammation & Allergy Drug Discovery 2024/2025影响因子:1.294 (RECENT ADV INFLAMM A) (2772-2708).  ...234
Total Citations:30; 2023 JIF:1.294; JIFRank: 290/354 ; Rank-JIF: 290; Number-of-JIF:354; 5 Year JIF:1.207; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.2; Immediacy Index:0.1; Immediacy Index-dealt:0.169; 2023 JCI:0.24; JCI Rank: 306/354 ; Total Articles:8; JCI Quartile:Q4; JCI Percentile:13.7; Eigenfactor:0; Normalized Eigenfactor:0.009; Article Influence Score:0.207; JIF Percentile:18.2; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:15; % of Articles in Citable items:0.5333; Cited Half-Life:NULL; Citing Half-Life:7.5; % of OA Gold:0; Publisher name:AMER INST MATHEMATICAL SCIENCES-AIMS; Publisher address:PO BOX 2604, SPRINGFIELD, Unite
投票 ESCI期刊Pharmacognosy Research 2024/2025影响因子:0.753 (PHARMACOGN RES) (0974-8490). (PHARMACOLOGY & PHARMACY)(药理学与药学)Emergin  ...234
Total Citations:1435; 2023 JIF:0.753; JIFRank: 317/354 ; Rank-JIF: 317; Number-of-JIF:354; 5 Year JIF:0.854; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.7; Immediacy Index:0.4; Immediacy Index-dealt:0.442; 2023 JCI:0.21; JCI Rank: 315/354 ; Total Articles:72; JCI Quartile:Q4; JCI Percentile:11.16; Eigenfactor:0; Normalized Eigenfactor:0.059; Article Influence Score:0.104; JIF Percentile:10.6; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:89; % of Articles in Citable items:0.809; Cited Half-Life:8.1; Citing Half-Life:10.6; % of OA Gold:0.9179; Publisher name:ROCKEFELLER UNIV PRESS; Publisher address:950 THIRD AVE, 2ND FLR, NEW YORK, USA
投票 ESCI期刊Ars Pharmaceutica 2024/2025影响因子:0.439 (ARS PHARM) (0004-2927). (PHARMACOLOGY & PHARMACY)(药理学与药学)Emerging Sources  ...234
Total Citations:176; 2023 JIF:0.439; JIFRank: 335/354 ; Rank-JIF: 335; Number-of-JIF:354; 5 Year JIF:0.592; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.4; Immediacy Index:<0.1; Immediacy Index-dealt:0.023; 2023 JCI:0.08; JCI Rank: 344/354 ; Total Articles:22; JCI Quartile:Q4; JCI Percentile:2.97; Eigenfactor:0; Normalized Eigenfactor:0.02; Article Influence Score:0.07; JIF Percentile:5.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:26; % of Articles in Citable items:0.8462; Cited Half-Life:6.6; Citing Half-Life:6.4; % of OA Gold:0.8351; Publisher name:ANNUAL REVIEWS; Publisher address:4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, USA,
投票 ESCI期刊Jundishapur Journal of Natural Pharmaceutical Products 2024/2025影响因子:1.141 (JUNDISHAPUR J NAT PH) (1735-7780). (P  ...234
Total Citations:556; 2023 JIF:1.141; JIFRank: 301/354 ; Rank-JIF: 301; Number-of-JIF:354; 5 Year JIF:0.996; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1; Immediacy Index:0.1; Immediacy Index-dealt:0.197; 2023 JCI:0.23; JCI Rank: 307/354 ; Total Articles:40; JCI Quartile:Q4; JCI Percentile:13.42; Eigenfactor:0; Normalized Eigenfactor:0.057; Article Influence Score:0.136; JIF Percentile:15.1; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:45; % of Articles in Citable items:0.8889; Cited Half-Life:7; Citing Half-Life:7.7; % of OA Gold:0.9926; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MILTON
投票 ESCI期刊Pharmaceutical Patent Analyst 2024/2025影响因子:1.892 (PHARM PAT ANAL) (2046-8954). (PHARMACOLOGY & PHARMACY)(药理学与药学)  ...234
Total Citations:253; 2023 JIF:1.892; JIFRank: 240/354 ; Rank-JIF: 240; Number-of-JIF:354; 5 Year JIF:1.862; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.7; Immediacy Index:0.4; Immediacy Index-dealt:0.443; 2023 JCI:0.29; JCI Rank: 293/354 ; Total Articles:8; JCI Quartile:Q4; JCI Percentile:17.37; Eigenfactor:0; Normalized Eigenfactor:0.039; Article Influence Score:0.338; JIF Percentile:32.3; JIF Quartile:Q3; AIS Quartile:Q4; Citable Items:13; % of Articles in Citable items:0.6154; Cited Half-Life:7; Citing Half-Life:5.4; % of OA Gold:0; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MILTON PARK
投票 ESCI期刊Therapeutic Delivery 2024/2025影响因子:3.157 (THER DELIV) (2041-5990). (PHARMACOLOGY & PHARMACY)(药理学与药学)Emerging Sour  ...234
Total Citations:2566; 2023 JIF:3.157; JIFRank: 136/354 ; Rank-JIF: 136; Number-of-JIF:354; 5 Year JIF:3.762; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.5; Immediacy Index:0.6; Immediacy Index-dealt:0.686; 2023 JCI:0.7; JCI Rank: 163/354 ; Total Articles:27; JCI Quartile:Q2; JCI Percentile:54.1; Eigenfactor:0.001; Normalized Eigenfactor:0.206; Article Influence Score:0.535; JIF Percentile:61.7; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:53; % of Articles in Citable items:0.5094; Cited Half-Life:7.8; Citing Half-Life:7.5; % of OA Gold:0.094; Publisher name:CAMBRIDGE UNIV PRESS; Publisher address:EDINBURGH BLDG, SHAFTESBURY RD, CAMBRI
投票 ESCI期刊Journal of the American College of Clinical Pharmacy 2024/2025影响因子:1.363 (J AM COLL CLIN PHARM) (NULL). (PHARMACO  ...234
Total Citations:880; 2023 JIF:1.363; JIFRank: 283/354 ; Rank-JIF: 283; Number-of-JIF:354; 5 Year JIF:1.675; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1; Immediacy Index:0.5; Immediacy Index-dealt:0.502; 2023 JCI:0.4; JCI Rank: 270/354 ; Total Articles:103; JCI Quartile:Q4; JCI Percentile:23.87; Eigenfactor:0.002; Normalized Eigenfactor:0.409; Article Influence Score:0.429; JIF Percentile:20.2; JIF Quartile:Q4; AIS Quartile:Q3; Citable Items:119; % of Articles in Citable items:0.8655; Cited Half-Life:2.9; Citing Half-Life:5.6; % of OA Gold:0.1386; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 ESCI期刊Journal of Psychedelic Studies 2024/2025影响因子:2.211 (J PSYCHEDELIC STUD) (NULL). (PHARMACOLOGY & PHARMACY)(药理学与药学)  ...234
Total Citations:314; 2023 JIF:2.211; JIFRank: 204/354 ; Rank-JIF: 204; Number-of-JIF:354; 5 Year JIF:NULL; 5 Year JIF Quartile:NULL; JIF Without Self Cites:1.9; Immediacy Index:0.4; Immediacy Index-dealt:0.481; 2023 JCI:0.89; JCI Rank: 103/354 ; Total Articles:22; JCI Quartile:Q2; JCI Percentile:67.21; Eigenfactor:0.001; Normalized Eigenfactor:0.194; Article Influence Score:0.361; JIF Percentile:49.1; JIF Quartile:Q3; AIS Quartile:NULL; Citable Items:28; % of Articles in Citable items:0.7857; Cited Half-Life:3.5; Citing Half-Life:6; % of OA Gold:0.9848; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 ESCI期刊Asian Journal of Pharmaceutical Research and Health Care 2024/2025影响因子:0.203 (ASIAN J PHARM RES HE) (2250-1444).  ...234
Total Citations:81; 2023 JIF:0.203; JIFRank: 350/354 ; Rank-JIF: 350; Number-of-JIF:354; 5 Year JIF:0.253; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.1; Immediacy Index:<0.1; Immediacy Index-dealt:0.033; 2023 JCI:0.08; JCI Rank: 344/354 ; Total Articles:56; JCI Quartile:Q4; JCI Percentile:2.97; Eigenfactor:0; Normalized Eigenfactor:0.008; Article Influence Score:0.036; JIF Percentile:1.3; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:61; % of Articles in Citable items:0.918; Cited Half-Life:NULL; Citing Half-Life:8.6; % of OA Gold:0.9771; Publisher name:LIPPINCOTT WILLIAMS & WILKINS; Publisher address:TWO COMMERCE SQ, 2001 MARKET ST,
投票 ESCI期刊Integrated Pharmacy Research and Practice 2024/2025影响因子:2.135 (INTEGR PHARM RES PRA) (2230-5254). (PHARMACOLOGY &  ...234
Total Citations:509; 2023 JIF:2.135; JIFRank: 210/354 ; Rank-JIF: 210; Number-of-JIF:354; 5 Year JIF:3.435; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2; Immediacy Index:0.3; Immediacy Index-dealt:0.307; 2023 JCI:0.64; JCI Rank: 183/354 ; Total Articles:15; JCI Quartile:Q3; JCI Percentile:48.45; Eigenfactor:0.001; Normalized Eigenfactor:0.11; Article Influence Score:0.767; JIF Percentile:40.8; JIF Quartile:Q3; AIS Quartile:Q2; Citable Items:18; % of Articles in Citable items:0.8333; Cited Half-Life:5.5; Citing Half-Life:6.6; % of OA Gold:0.9792; Publisher name:TARAS SHEVCHENKO NATL UNIV KYIV; Publisher address:TARAS SHEVCHENKO NATL UNIV K
投票 ESCI期刊Journal of Research in Pharmacy 2024/2025影响因子:0.614 (J RES PHARM) (2630-6344). (PHARMACOLOGY & PHARMACY)(药理学与药学)E  ...234
Total Citations:480; 2023 JIF:0.614; JIFRank: 326/354 ; Rank-JIF: 326; Number-of-JIF:354; 5 Year JIF:0.904; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.6; Immediacy Index:0.2; Immediacy Index-dealt:0.269; 2023 JCI:0.21; JCI Rank: 315/354 ; Total Articles:189; JCI Quartile:Q4; JCI Percentile:11.16; Eigenfactor:0; Normalized Eigenfactor:0.102; Article Influence Score:0.109; JIF Percentile:8.1; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:197; % of Articles in Citable items:0.9594; Cited Half-Life:3.4; Citing Half-Life:8.3; % of OA Gold:0.8906; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 ESCI期刊INTERNATIONAL JOURNAL OF PHARMACY PRACTICE 2024/2025影响因子:1.581 (INT J PHARM PRACT) (0961-7671). (PHARMACOLOGY & P  ...234
Total Citations:1672; 2023 JIF:1.581; JIFRank: 265/354 ; Rank-JIF: 265; Number-of-JIF:354; 5 Year JIF:2.145; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.3; Immediacy Index:0.7; Immediacy Index-dealt:0.711; 2023 JCI:0.39; JCI Rank: 273/354 ; Total Articles:64; JCI Quartile:Q4; JCI Percentile:23.02; Eigenfactor:0.002; Normalized Eigenfactor:0.347; Article Influence Score:0.499; JIF Percentile:25.3; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:77; % of Articles in Citable items:0.8312; Cited Half-Life:6.1; Citing Half-Life:6.1; % of OA Gold:0.3607; Publisher name:SPRINGER HEIDELBERG; Publisher address:TIERGARTENSTRASSE 17, HEIDELBERG, GE
投票 ESCI期刊Traditional & Kampo Medicine 2024/2025影响因子:0.733 (TRADIT KAMPO MED) (NULL). (PHARMACOLOGY & PHARMACY)(药理学与药学)Emer  ...234
Total Citations:93; 2023 JIF:0.733; JIFRank: 317/354 ; Rank-JIF: 317; Number-of-JIF:354; 5 Year JIF:NULL; 5 Year JIF Quartile:NULL; JIF Without Self Cites:0.6; Immediacy Index:0.2; Immediacy Index-dealt:0.276; 2023 JCI:0.21; JCI Rank: 315/354 ; Total Articles:20; JCI Quartile:Q4; JCI Percentile:11.16; Eigenfactor:0; Normalized Eigenfactor:0.002; Article Influence Score:0.019; JIF Percentile:10.6; JIF Quartile:Q4; AIS Quartile:NULL; Citable Items:30; % of Articles in Citable items:0.6667; Cited Half-Life:NULL; Citing Half-Life:8; % of OA Gold:0.2955; Publisher name:UNIV ALCALA HENARES, SERVICIO PUBLICACIONES; Publisher address:COLEGIO MAYOR DE
投票 ESCI期刊Canadian Pharmacists Journal 2024/2025影响因子:1.626 (CAN PHARM J) (1715-1635). (PHARMACOLOGY & PHARMACY)(药理学与药学)Emer  ...234
Total Citations:801; 2023 JIF:1.626; JIFRank: 259/354 ; Rank-JIF: 259; Number-of-JIF:354; 5 Year JIF:2.128; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.3; Immediacy Index:0.4; Immediacy Index-dealt:0.413; 2023 JCI:0.32; JCI Rank: 290/354 ; Total Articles:30; JCI Quartile:Q4; JCI Percentile:18.22; Eigenfactor:0.001; Normalized Eigenfactor:0.145; Article Influence Score:0.439; JIF Percentile:27; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:32; % of Articles in Citable items:0.9375; Cited Half-Life:6.3; Citing Half-Life:5.9; % of OA Gold:0.5981; Publisher name:BEILSTEIN-INSTITUT; Publisher address:TRAKEHNER STRASSE 7-9, FRANKFURT AM MAIN
投票 ESCI期刊Expert Review of Precision Medicine and Drug Development 2024/2025影响因子:1.122 (EXPERT REV PRECIS ME) (2380-8993).  ...234
Total Citations:251; 2023 JIF:1.122; JIFRank: 301/354 ; Rank-JIF: 301; Number-of-JIF:354; 5 Year JIF:1.377; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1; Immediacy Index:<0.1; Immediacy Index-dealt:0.006; 2023 JCI:0.16; JCI Rank: 327/354 ; Total Articles:0; JCI Quartile:Q4; JCI Percentile:7.77; Eigenfactor:0; Normalized Eigenfactor:0.066; Article Influence Score:0.304; JIF Percentile:15.1; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:2; % of Articles in Citable items:0; Cited Half-Life:5; Citing Half-Life:6.1; % of OA Gold:0.175; Publisher name:CURRENT MEDICINE GROUP; Publisher address:400 MARKET STREET, STE 700, PHILADELPHIA, USA, PA,
投票 ESCI期刊Journal of Pharmacy and Bioallied Sciences 2024/2025影响因子:0.708 (J PHARM BIOALLIED SC) (0976-4879). (PHARMACOLOGY  ...234
Total Citations:3434; 2023 JIF:0.708; JIFRank: 317/354 ; Rank-JIF: 317; Number-of-JIF:354; 5 Year JIF:1.293; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.7; Immediacy Index:0.1; Immediacy Index-dealt:0.107; 2023 JCI:0.2; JCI Rank: 319/354 ; Total Articles:317; JCI Quartile:Q4; JCI Percentile:10.03; Eigenfactor:0.002; Normalized Eigenfactor:0.384; Article Influence Score:0.19; JIF Percentile:10.6; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:350; % of Articles in Citable items:0.9057; Cited Half-Life:8; Citing Half-Life:12.1; % of OA Gold:0.9811; Publisher name:INDERSCIENCE ENTERPRISES LTD; Publisher address:WORLD TRADE CENTER BLDG, 29
投票 ESCI期刊International Journal of Pharmaceutical Investigation 2024/2025影响因子:0.438 (INT J PHARM INVESTIG) (2230-973X). (PH  ...234
Total Citations:1033; 2023 JIF:0.438; JIFRank: 335/354 ; Rank-JIF: 335; Number-of-JIF:354; 5 Year JIF:0.535; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.4; Immediacy Index:0.1; Immediacy Index-dealt:0.138; 2023 JCI:0.13; JCI Rank: 332/354 ; Total Articles:89; JCI Quartile:Q4; JCI Percentile:6.36; Eigenfactor:0; Normalized Eigenfactor:0.04; Article Influence Score:0.066; JIF Percentile:5.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:113; % of Articles in Citable items:0.7876; Cited Half-Life:9; Citing Half-Life:8.9; % of OA Gold:0.6764; Publisher name:SPRINGER HEIDELBERG; Publisher address:TIERGARTENSTRASSE 17, HEIDELBERG, GERMANY, D
投票 ESCI期刊Journal of Research in Pharmacy Practice 2024/2025影响因子:0.814 (J RES PHARM PRACT) (2319-9644). (PHARMACOLOGY & PHA  ...234
Total Citations:500; 2023 JIF:0.814; JIFRank: 311/354 ; Rank-JIF: 311; Number-of-JIF:354; 5 Year JIF:1.201; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.8; Immediacy Index:<0.1; Immediacy Index-dealt:0.093; 2023 JCI:0.25; JCI Rank: 303/354 ; Total Articles:5; JCI Quartile:Q4; JCI Percentile:14.55; Eigenfactor:0; Normalized Eigenfactor:0.071; Article Influence Score:0.261; JIF Percentile:12.3; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:5; % of Articles in Citable items:1; Cited Half-Life:6.9; Citing Half-Life:NULL; % of OA Gold:0.8868; Publisher name:IOP PUBLISHING LTD; Publisher address:TEMPLE CIRCUS, TEMPLE WAY, BRISTOL, ENGLAND, BS
投票 ESCI期刊Pharmacy & Pharmacology-Farmatsiya i Farmakologiya 2024/2025影响因子:0.573 (PHARM PHARMACOL-RUSS) (2307-9266). (PHARM  ...234
Total Citations:345; 2023 JIF:0.573; JIFRank: 331/354 ; Rank-JIF: 331; Number-of-JIF:354; 5 Year JIF:0.522; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.4; Immediacy Index:0.4; Immediacy Index-dealt:0.438; 2023 JCI:0.09; JCI Rank: 343/354 ; Total Articles:26; JCI Quartile:Q4; JCI Percentile:3.25; Eigenfactor:0; Normalized Eigenfactor:0.022; Article Influence Score:0.06; JIF Percentile:6.6; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:34; % of Articles in Citable items:0.7647; Cited Half-Life:9.1; Citing Half-Life:4.6; % of OA Gold:0.9835; Publisher name:ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MILTON
下一页 »
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-7-8 09:02
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
返回顶部 返回版块